• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

UHN and Helix Launch Canada’s Largest Population Genomics Initiative

by Jasmine Pennic 11/07/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
UHN and Helix Launch Canada’s Largest Population Genomics Initiative

What You Should Know: 

– University Health Network’s (UHN’s) Princess Margaret Cancer Centre and Helix, a precision health organization, today announced a landmark partnership to launch one of the largest population genomics studies in Canada.

– The initiative, known as the OurGenes Study, aims to enroll up to 100,000 participants over five years, advancing precision medicine and the early detection of hereditary health risks.

Targeting Actionable Hereditary Health Risks

The OurGenes Study is focused on providing participants with screening for well-established genetic conditions. These conditions are classified as Centers for Disease Control and Prevention (CDC) Tier 1 genomic conditions due to their clinical actionability and population health impact.

Specific conditions being screened include:

  • Hereditary Breast and Ovarian Cancer (BRCA1/2)
  • Lynch Syndrome (associated with colorectal and other cancers)
  • Familial Hypercholesterolemia (an inherited condition linked to high cholesterol and cardiovascular risk)

The screening results will allow participants and their healthcare teams to make proactive decisions about their health, with the potential to delay, reduce, or even prevent cancer or heart disease.

Leveraging Scale to Overcome Underdiagnosis

The study is led by Dr. Raymond Kim, Medical Director of Cancer Early Detection at Princess Margaret. Participants’ samples will be sent to Helix for whole exome sequencing, which comprehensively analyzes the genetic code to identify meaningful variations.

  • Timeline and Support: Results will be returned to participants within eight to twelve weeks, along with access to genetic counselling and ongoing genomic insights about their health throughout their lifetime.
  • Research Impact: Participants’ genetic information, which includes the entire protein-coding regions of the genome, will also be available to support future research at UHN.

The sheer scale of the study is critical to improving current healthcare deficiencies. Population studies often find that 90% of patients who carry serious disease risk are missed in conventional care. By conducting screening at scale, the Princess Margaret Cancer Centre, Canada’s largest comprehensive cancer centre, will also be able to identify and address health risks that may be disproportionately affecting certain communities.

“UHN is moving beyond the current standard of care, offering patients and their providers a powerful tool to take greater control of their health outcomes,” said Dr. Brad Wouters, UHN’s Executive Vice President of Science and Research. Participation in this research study is voluntary and free.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |